Psychedelic Slang and Terminology Guide

Common Trip Terminology

The word "trip" is the most widely used informal term for a psychedelic experience. Its origins in American slang date to the 1950s and early 1960s, likely drawing on the sense of a journey or voyage to an unfamiliar destination. In common usage, it refers to any psychedelic experience regardless of duration, intensity, or substance. "Tripping" as a verb describes the active state of being under the influence. Within community usage, experiences are often further described by their subjective quality: a "good trip" involves predominantly positive emotions, insights, and perceptual enjoyment; a "bad trip" involves fear, paranoia, physical discomfort, or psychological overwhelm. The term "challenging experience" is preferred in therapeutic contexts as a more accurate and less judgement-laden description of difficult psychedelic states, which are increasingly understood as potentially valuable rather than purely negative.

The temporal structure of a psychedelic experience has generated its own vocabulary. "Coming up" refers to the onset phase as the substance begins to take effect — typically characterised by anticipation, sensory brightening, and the beginning of perceptual changes. "Peaking" describes the period of maximum effect, when the full intensity of the experience is present. "Coming down" refers to the gradual return toward baseline as the substance is metabolised and its effects diminish. The "afterglow" is a period following the return to baseline — which may last hours or even days — characterised by emotional warmth, cognitive openness, and a sense of refreshment or clarity. The afterglow is widely reported following psilocybin experiences and has been documented in clinical research as a distinct pharmacological and psychological phase.

Perceptual phenomena during psychedelic states have generated numerous descriptive terms. "Visuals" refers to any altered visual perception, from subtle colour enhancement and pattern intensification to complex, immersive hallucinations. "Trails" (or tracers) describe the visual effect where moving objects leave a smeared after-image. "Closed-eye visuals" (CEVs) are geometric or narrative visual experiences perceived with eyes closed. "Open-eye visuals" (OEVs) are perceptual alterations visible in the external environment. "Synesthesia" describes the cross-modal blending of senses — hearing colours, seeing sounds — that is common at moderate to high doses. "Ego dissolution" or "ego death" refers to the partial or complete dissolution of the sense of a separate self, one of the most profound and psychologically significant experiences possible at high doses, associated with mystical-type experiences in clinical research.

Dosing Language

Dosing vocabulary in the psychedelic community reflects a range of intensities and intentions. "Microdose" refers to a sub-perceptual dose — typically one-tenth to one-twentieth of a full experience dose — taken for subtle cognitive or emotional benefits without altering ordinary function. A "threshold dose" is the minimum amount required to produce any perceptible psychedelic effect, typically involving mild sensory changes, mood shift, and perhaps faint visuals. A "light dose" or "low dose" produces clear but manageable effects suitable for introspective work while maintaining most cognitive and emotional stability. A "moderate dose" or "common dose" produces more pronounced perceptual changes, deeper emotional access, and the beginning of significant alterations in self-perception. A "high dose" produces intense effects including strong hallucinations, substantial ego softening, and significant emotional depth.

The "heroic dose" is a term most associated with Terence McKenna, who used it to describe doses large enough to produce a complete and transformative psychedelic experience — typically 5 grams or more of dried Psilocybe cubensis. McKenna advocated for silent darkness during heroic doses, arguing that the full psychedelic revelation was only accessible at these high levels. The term carries connotations of both courage and risk, and its use in community contexts reflects the genuine unpredictability of very high dose experiences. "Floor dose" or "ceiling dose" are less standardised terms sometimes used to describe the practical boundaries of a person's comfortable dosing range — the floor being the minimum effective dose and the ceiling being the maximum tolerable dose before the experience becomes unmanageable.

"Stacking" refers to combining substances in a single session, typically with the intention of enhancing or modifying the effects of the primary psychedelic. In the mushroom community, the most widely discussed stack is the "Stamets Stack" of psilocybin plus lion's mane mushroom plus niacin, used in the context of microdosing. "Potentiators" are substances used to enhance or prolong psychedelic effects — including harmala alkaloids (from Syrian rue or ayahuasca vine), which inhibit MAO enzymes that metabolise psilocin, effectively extending and intensifying the experience. Stacking and potentiating carry additional safety considerations including interaction risks, and are not recommended for beginners. "Set and setting" — discussed in more detail in the FAQ below — is arguably the most important phrase in all of psychedelic harm reduction.

Community Slang

Online psychedelic communities, particularly on Reddit (r/PsychedelicExperiences, r/shrooms, r/microdosing), Shroomery, and Bluelight, have developed a distinctive vocabulary for discussing experiences, species, cultivation, and harm reduction. "Shroomies" or "shrooms" are informal terms for psilocybin mushrooms. "Golden teachers," "PE" (Penis Envy), and "B+" are names for popular Psilocybe cubensis strains used in cultivation, each with different reputations for potency and growing characteristics. "SAB" stands for Still Air Box, a simple contamination-reducing enclosure for cultivation work. "Agar" and "WBS" (wild bird seed) are terms from the cultivation world relating to growing substrates. The phrase "trust the fungi" is used in community contexts to encourage surrendering to the experience rather than resisting it — a piece of experiential advice that has become something of a cultural motto.

Reports posted in community spaces often follow informal conventions. "Trip reports" are first-person narratives describing a specific psychedelic experience, typically including dose, setting, timeline, and subjective description. These reports have significant value as observational data and as shared learning material. "SWIM" (Someone Who Isn't Me) was historically used as a legal fiction to describe personal substance use in third-person form, though this convention has largely been abandoned in most communities as legally ineffective and narratively awkward. "Harm reduction" as a phrase signals the community's commitment to providing practical, non-judgmental safety information. "Set and setting" vocabulary, described below, and integration language have increasingly crossed from clinical contexts into community use as the psychedelic renaissance has made therapeutic concepts more widely accessible.

The phrase "psychedelic renaissance" itself has become a cultural touchstone, describing the revival of scientific and medical research into psychedelic substances after decades of prohibition-era suppression. This period — roughly from 2000 to the present — is characterised by a new wave of clinical trials, regulatory breakthroughs (such as FDA Breakthrough Therapy designations for psilocybin and MDMA), and growing public awareness of psychedelics' therapeutic potential. "Decriminalisation" and "legalisation" are frequently confused in community discussions: decriminalisation typically removes criminal penalties for personal possession while keeping commercial production and supply illegal; legalisation typically refers to a regulated legal market. Oregon's Measure 109 (2020) established the first regulated psilocybin services framework in the United States, distinct from both decriminalisation and full legalisation.

Integration Vocabulary

"Integration" is the process of incorporating insights, emotions, and perspective shifts from a psychedelic experience into everyday life. The term has become central to therapeutic and community approaches to psychedelic use, reflecting the understanding that the experience itself is not the end of the process — rather, it opens material that must be actively worked with over the following days, weeks, and months to realise lasting benefit. Integration can take many forms: journaling, therapy with an integration-specialised therapist, art-making, movement practices, community discussion, and contemplative practices are all used. The distinction between a psychedelic experience and its integration mirrors the difference between planting a seed and tending the plant that grows — the session opens potential that life choices and intentional work must cultivate.

An "integration therapist" is a mental health professional with training or experience in supporting clients through the psychological aftermath of psychedelic experiences. Integration therapy draws on a range of modalities including somatic therapy, Internal Family Systems (IFS), Acceptance and Commitment Therapy (ACT), and depth psychology. Integration circles are peer-support groups — typically facilitated but not professionally led — in which people share and discuss their experiences in a structured, confidential setting. The Multidisciplinary Association for Psychedelic Studies (MAPS) and the Zendo Project offer training for integration facilitators and crisis support specialists respectively. "Re-entry" is a term for the transitional period immediately following a session when a person is returning to ordinary reality but has not yet fully integrated the experience — this is considered a sensitive and important window requiring appropriate pacing and support.

"Spiritual emergency" is a concept developed by psychiatrists Stanislav and Christina Grof to describe psychological crises that arise from intense non-ordinary experiences, including psychedelic sessions, but also meditation retreats, spontaneous mystical experiences, and other encounters with non-ordinary consciousness. Rather than pathologising these experiences as psychotic breaks, the Grofs proposed that they represent a fundamental reorganisation of the psyche that, if supported appropriately, can lead to significant psychological growth. This framework significantly influenced how the therapeutic psychedelic community conceptualises difficult experiences, and it is the theoretical foundation for crisis support services like the Zendo Project, Fireside Project, and Psymposia's harm reduction resources. Understanding spiritual emergency as distinct from psychosis is an important harm reduction consideration when supporting someone in distress following a difficult psychedelic experience.

Frequently Asked Questions

What does ego death mean?

Ego death — also called ego dissolution — refers to the temporary dissolution of the boundary between the sense of self and the rest of experience. In ordinary consciousness, there is a persistent background sense of "I" that observes, interprets, and maintains a continuous personal narrative. At high doses of psilocybin, LSD, or DMT, this self-referential processing can temporarily cease, producing an experience in which the usual subject-object distinction disappears. What remains is pure experience without a separate experiencer — often described as a sense of infinite expansion, unity with all things, or complete cessation of individual identity. This experience can be profoundly liberating and mystical, or profoundly terrifying, depending on the person's preparation, set and setting, and relationship with the loss of control that ego dissolution requires. Clinical research has identified ego dissolution, measured by the Ego Dissolution Inventory (EDI), as one of the strongest predictors of positive long-term therapeutic outcomes in psilocybin therapy.

What is the heroic dose and where does the term come from?

The term "heroic dose" comes from Terence McKenna, the American ethnobotanist and psychedelic author who became one of the most influential voices in psychedelic culture from the 1980s until his death in 2000. McKenna used "heroic dose" to describe taking 5 grams or more of dried Psilocybe cubensis mushrooms alone, in silent darkness, with eyes closed — a protocol he advocated as the most direct route to a complete and genuinely transformative psychedelic experience. He considered lower doses insufficiently potent to produce the full range of mushroom consciousness and encouraged experienced users to confront the most intense possible experience. The heroic dose is associated with very high probability of ego dissolution, intense and complex visionary states, and significant emotional demand. It is not appropriate for beginners and carries meaningful psychological risks for anyone without extensive preparation, integration support, and a stable psychological baseline. The term is used descriptively in community contexts without implying a recommendation.

What is the origin of the concept of set and setting?

The concept of "set and setting" was articulated most clearly by Harvard psychologist Timothy Leary in the early 1960s, drawing on the work of psychedelic research pioneers including Humphry Osmond and Al Hubbard. "Set" refers to the mindset, intentions, expectations, mood, and psychological state that a person brings to a psychedelic experience. "Setting" refers to the physical and social environment in which the experience occurs — the space, the people present, the lighting, sound, and general atmosphere. Leary and his colleagues argued that the content and character of a psychedelic experience is not simply a pharmacological function of the substance but is powerfully shaped by these contextual variables. This insight remains the cornerstone of psychedelic harm reduction and therapeutic protocol design, half a century after it was first articulated. Clinical research has consistently confirmed that set and setting variables — particularly the therapeutic alliance between participant and guide, and the quality of the physical environment — are among the strongest predictors of outcome in psilocybin therapy.

Is the word "trip" appropriate in therapeutic contexts?

The word "trip" is considered informal and somewhat reductive in formal therapeutic and clinical contexts, where terms like "session," "experience," or "journey" are generally preferred. "Trip" carries cultural associations with recreational use and counterculture that can undermine the seriousness and intentionality of therapeutic work. Some therapeutic frameworks specifically avoid it to ensure that the clinical setting is understood as distinct from recreational experimentation. "Journey" is frequently used as an alternative because it implies purposeful movement toward a destination — a useful metaphor for the therapeutic intention of a psychedelic session. In community and harm reduction contexts, "trip" and "session" are both used freely without strong preference. In person-to-person conversation, following the language preferences of the individual and the context is the most respectful approach; some people find "journey" overly precious while others find "trip" too casual for serious introspective work.

What is the difference between a guide and a sitter?

The terms "guide" and "sitter" both describe people who are present with someone during a psychedelic session without themselves ingesting the substance, but they differ in their level of active involvement. A "sitter" is primarily a safety presence — someone who stays with the journeyer, ensures physical safety, provides calm reassurance if needed, and handles practical matters like water, blankets, or managing the environment. The sitter role is relatively passive; the sitter does not direct the experience. A "guide" or "facilitator" takes a more active role: preparing the participant with pre-session intention work, potentially influencing the direction of the experience through music selection and presence, offering verbal support or gentle reorientation during the session, and supporting integration afterward. In clinical research trials, guides are trained therapists who conduct both preparatory therapy sessions and integration therapy after the session. The terms overlap and are not consistently distinguished across all communities and contexts.

What is the afterglow?

The afterglow is a period following the return to baseline consciousness after a psychedelic session, typically lasting from several hours to two or three days, characterised by positive mood, emotional openness, cognitive clarity, and a sense of refreshment or renewal. People in afterglow states often report feeling emotionally lighter, more connected to others, less burdened by habitual worries, and more appreciative of simple experiences. The afterglow appears to be partly pharmacological — related to the residual effects of serotonergic receptor modulation and possibly to BDNF expression — and partly psychological, reflecting the emotional release and perspective shift that may have occurred during the experience. Clinical research has documented the afterglow as a distinct measurable phase and has noted that the emotional content of the afterglow period — whether it is characterised by gratitude, grief, integration, or confusion — often predicts longer-term outcomes. Gentle scheduling and emotional support during this window is considered good practice in therapeutic contexts.

What are the coming-up and peaking phases?

Coming up and peaking are informal terms for the onset and maximum-effect phases of a psychedelic experience, respectively. The coming-up phase begins when the effects of the substance first become perceptible — typically 20–60 minutes after oral ingestion of psilocybin mushrooms — and involves the gradual intensification of effects over the following 60–90 minutes. This phase is characterised by increasing sensory sensitivity, mood shift, physical sensations such as yawning, tingling, or nausea (particularly with mushrooms), and building perceptual changes. Many people find the coming-up phase the most anxious part of the experience because they are in transition between ordinary consciousness and the altered state. Peaking refers to the period of maximum effect, typically occurring 90–180 minutes after ingestion, during which the full intensity of the experience is present. The peak phase may last 1–3 hours depending on dose. After the peak, the experience gradually diminishes — the coming-down phase — over 2–4 more hours.

What does integration mean in the psychedelic context?

In the psychedelic context, integration refers to the active process of incorporating the insights, emotions, and perspective changes arising from a psychedelic experience into everyday life and consciousness. The term is borrowed from Jungian psychology, where integration describes bringing unconscious material into conscious awareness and embodied reality. A psychedelic session can surface profound insights about relationships, values, unprocessed grief, creative direction, or existential questions — but these insights only become transformative if they are worked with deliberately in the days, weeks, and months following the session. Integration practices include journaling, therapy (particularly with an integration-specialised therapist), discussing the experience with trusted others, making concrete life changes prompted by session insights, and creative expression. The field of psychedelic integration has grown substantially as clinical research has highlighted that the session itself is one component of a therapeutic arc that requires sustained engagement to be fully beneficial.

What is a "bad trip" and how should it be understood?

A "bad trip" is informal language for a psychedelic experience that is predominantly characterised by fear, paranoia, confusion, emotional overwhelm, or psychological distress. Bad trips range from uncomfortable and anxiety-provoking to genuinely terrifying, and at high doses can involve experiences of extreme dread, existential horror, or a sense of permanent insanity. They are more common with high doses, in unfamiliar or stressful settings, with strained psychological states or unresolved trauma at the surface, or when the substance is taken without adequate preparation or support. In therapeutic contexts, "challenging experience" is often preferred over "bad trip" because it is more accurately descriptive and because research has shown that psychologically challenging sessions — including those involving strong fear or emotional pain — frequently lead to positive long-term outcomes when supported and integrated appropriately. The key intervention for a difficult experience is surrendering rather than resisting, with grounded physical anchoring (breathing, contact with surfaces, music), reassurance, and if necessary, a benzodiazepine to reduce the intensity.

What is the difference between a floor dose and a threshold dose?

These terms are sometimes used interchangeably but have slightly different meanings in careful usage. A threshold dose is the minimum amount of a substance required to produce any perceptible psychedelic effect — the very bottom of the dose-response curve where subtle changes in mood, sensory sensitivity, or cognition become detectable. It is defined by pharmacological sensitivity to the substance and varies between individuals. A floor dose, in microdosing contexts specifically, refers to the minimum dose that produces any subjective benefit for a particular individual — which may be higher than the pharmacological threshold for perceptibility. Some people find that doses below their floor dose feel like a simple placebo. The ceiling dose, by contrast, is the maximum a person finds comfortable or manageable — beyond which the experience becomes too intense or overwhelming to work with productively. These personal ranges (floor to ceiling) are established through careful dose-finding practice and form the individual's "working dose range."